Nodiarrhea affects approximately 20-25% of GLP-1 users, meaning the majority tolerate these medications without significant digestive disruption
The study noted that patients lost 2.5% of total body weight within four weeks of use
If you are an existing Livongo/Teladoc participant and a GLP-1 for weight loss medication user, you will be automatically migrated to the Weight Management for GLP-1 users program
SEMAGLUTIDE WEIGHT LOSS INJECTION THERAPY IN CINCINNATI TRANSFORM, REDUCE, RENEW: SEMAGLUTIDE FOR EFFECTIVE WEIGHT MANAGEMENT Cincinnati Plastic Surgery now offers semaglutide weight loss injections
Some common side effects of Mounjaro include urinary tract infections, genital infections, and increased urination
Other early indicators may include new or worsening food sensitivities and skin conditions like rashes, acne, or eczema